Maihemuti Yakufu

Maihemuti Yakufu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JLJiashun Li
Jiashun Li
AAAinikaer Abulaiti
Ainikaer Abulaiti
DLDeyu Li
Deyu Li
YZYan Zhao
Yan Zhao
PWPaerhati Wahafu
Paerhati Wahafu
ZLZhen Liu
Zhen Liu
Objective: BCMA- or GPRC5D-directed CD3 bispecific antibodies are important T-cell–redirecting therapies for relapsed/refractory multiple myeloma (RRMM). We evaluated their efficacy, safety, and certainty of evidence. Methods: We searched the Cochrane Library, Embase, PubMed, Scopus, and Web of Science from inception to February 5, 2026. Prospective clinical trials and real-world studies of BCMA×CD3 or GPRC5D×CD3 bispecific antibodies in RRMM with extractable efficacy and safety data were included. Main efficacy outcomes were progression-free survival (PFS), stringent complete response (sCR), complete response (CR), complete response or better (≥CR), very good partial response or better (≥VGPR), and overall response rate (ORR). Safety outcomes included cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), infection, neutropenia, anemia, and thrombocytopenia. Single-arm proportional meta-analyses, sensitivity analyses, meta-regression, and subgroup analyses were performed using STATA/MP 18.0. Methodological quality and evidence certainty were assessed using MINORS and GRADE, respectively. Results: Fifteen studies, including 17 independently extractable cohorts and 1,900 patients, were analyzed. The pooled PFS was 8.76 months (95% CI, 6.82–11.13). The pooled rates of sCR, CR, ≥CR, ≥VGPR, and ORR were 28.7%, 18.1%, 38.2%, 51.0%, and 65.9%, respectively. The pooled incidences of CRS, ICANS, infection, grade ≥3 infection, neutropenia, and grade ≥3 neutropenia were 67.5%, 9.7%, 60.3%, 38.3%, 54.7%, and 42.6%, respectively. MINORS showed moderate-to-high methodological quality. GRADE showed low-to-very low certainty of evidence. Conclusion: BCMA- or GPRC5D-directed CD3 bispecific antibodies showed clinically meaningful antitumor activity in RRMM. However, current evidence is mainly from single-arm trials and retrospective real-world studies, and certainty of evidence remains low to very low. These findings should be interpreted cautiously, with particular attention to infection and neutropenia in clinical practice.

11 November 2025 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
PYParhat Yasin
Parhat Yasin
SDShiming Dong
Shiming Dong
ZAZubaidanmu Aizezi
Zubaidanmu Aizezi
YYYasen Yimit
Yasen Yimit
AYAlimujiang Yusufu
Alimujiang Yusufu
XSXinghua Song
Xinghua Song
Diabetic foot complications, including infections and osteomyelitis, pose significant health risks, with high prevalence and amputation rates. Differentiating diabetic foot infection (DFI) from osteomyelitis (OM) is challenging due to overlapping symptoms and limitations of current diagnostic methods. This study aimed to develop and validate an explainable machine learning (ML) model using routine blood biomarkers to improve differential diagnosis and provide a clinically accessible tool. This retrospective, two-center study included 3,612 patients diagnosed with either DFI (n = 1,699) or OM (n = 1,913). Data from Center 1 (n = 3271) were used for model development (75% training, 25% internal validation), and data from Center 2 (n = 341) served as an independent external validation cohort. A robust feature selection pipeline identified the most predictive routine biomarkers. Multiple machine learning classifiers were trained and evaluated, with the top-performing model selected based on the area under the receiver operating characteristic curve (AUC), Brier score, and other key metrics. Explainable AI (XAI) techniques (SHAP, LIME) were used to ensure model transparency. A web-based calculator was developed for clinical translation. A LightGBM model using only six biomarkers—Age, HbA1c, Creatinine, Albumin, ESR, and Sodium—was selected as the final model. It achieved an AUC of 0.879 (95% CI 0.854–0.902) in internal validation and demonstrated excellent, generalizable performance in the external cohort with an AUC of 0.942 (95% CI 0.936–0.950). The model was well-calibrated and showed significant clinical utility in decision curve analysis. SHAP analysis quantified the specific contribution of each biomarker to individual predictions, enhancing interpretability. The final model was deployed as a user-friendly, publicly accessible web calculator. An externally validated machine learning model based on six routine blood biomarkers can accurately and reliably differentiate DFI from OM. The model demonstrated high discriminative performance and clinical utility. Deployed as a transparent web calculator with integrated explainable AI, this low-cost tool has the potential to aid clinicians in diagnostic decision-making, particularly in resource-limited settings. Not applicable.

8 January 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
JLJiashun Li
Jiashun Li
ZLZhen Liu
Zhen Liu
ZWZheng Wang
Zheng Wang
DLDeyu Li
Deyu Li
HZHeng Zhang
Heng Zhang
AHAbuduwupuer Haibier
Abuduwupuer Haibier
Objective: Periprosthetic joint infection (PJI) represents a severe and devastating complication following primary total knee arthroplasty (TKA), leading to higher morbidity and implant failure. However, existing evidence regarding its risk factors remains inconsistent. Method: PubMed, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), Wanfang Database, VIP Chinese Journal Database, and the Chinese Biomedical Literature Service System (SinoMed) were searched for primary studies from the database inception to August 2025. Data were managed with EndNote X9 software, meta-analyses were performed using Review Manager 5.4, infection risk was analyzed using STATA 18, and the comprehensive incidence rate of PJI was analyzed using R 4.5.1. Results: A total of 1,569 studies were identified, of which 20 were included in this systematic review. The meta-analysis including 20 studies analyzed eight risk factors: longer operation time (OR = 9.10, 95% CI: 7.66–10.80), obesity (OR = 13.95, 95% CI: 12.06–16.14), male gender (OR = 2.67, 95% CI: 1.80–3.95), diabetes (OR = 2.98, 95% CI: 2.27–3.92), longer hospital stay (OR = 1.73, 95% CI: 1.38–2.16), use of immunosuppressants (OR = 5.76, 95% CI: 2.77–11.98), hypoalbuminemia (OR = 6.24, 95% CI: 4.00–9.73), and underlying systemic inflammatory disease (OR = 3.47, 95% CI: 1.92–6.27). All identified risk factors were associated with an increased risk of developing PJI after primary TKA. Conclusion: The meta-analysis confirmed that longer operative time, obesity, male gender, diabetes, longer hospital stay, use of immunosuppressants, hypoalbuminemia, and underlying systemic inflammatory disease are risk factors for PJI after primary TKA. This systematic review and meta-analysis provide Level II evidence (according to the Oxford Centre for Evidence-Based Medicine criteria) for the identified risk factors.

30 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PYParhat Yasin
Parhat Yasin
YYYasen Yimit
Yasen Yimit
AAAbuduainijiang Abulimiti
Abuduainijiang Abulimiti
HLHaopeng Luan
Haopeng Luan
CPCong Peng
Cong Peng
XSXinghua Song
Xinghua Song
Knee abnormalities, such as meniscus tears and ligament injuries, are common in clinical practice and pose significant diagnostic challenges. While traditional imaging techniques—X-ray, Computed Tomography (CT) scan, and Magnetic Resonance Imaging (MRI)—are vital for assessment. However, X-rays and CT scans often fail to adequately visualize soft tissue injuries, and MRIs can be costly and time-consuming. To overcome these limitations, we developed an innovative AI-driven approach that allows for the detection of soft tissue abnormalities directly from X-ray images—a capability traditionally reserved for MRI or arthroscopy. We conducted a retrospective study with 4,215 patients from two medical centers, utilizing knee X-ray images annotated by orthopedic surgeons. The YOLOv11 model automated knee localization, while five convolutional neural networks—ResNet152, DenseNet121, MobileNetV3, ShuffleNetV2, and VGG19—were adapted for multi-label classification of eight conditions: meniscus tears (MENI), anterior cruciate ligament tears (ACL), posterior cruciate ligament injuries (PCL), medial collateral ligament injuries (MCL), lateral collateral ligament injuries (LCL), joint effusion (EFFU), bone marrow edema or contusion (CONT), and soft tissue injuries (STI). Data preprocessing involved normalization and Region of Interest (ROI) extraction, with training enhanced by spatial augmentations. Performance was assessed using mean average precision (mAP), F1-scores, and area under the curve (AUC). We also developed a Windows-based PyQt application and a Flask Web application for clinical integration, incorporating explainable AI techniques (GradCAM, ScoreCAM) for interpretability. The YOLOv11 model achieved precise knee localization with a mAP@0.5 of 0.995. In classification, ResNet152 outperformed others, recording a mAP of 90.1% in internal testing and AUCs up to 0.863 (EFFU) in external testing. End-to-end performance on the external set yielded a mAP of 86.1% and F1-scores of 84.0% with ResNet152. The Windows and web applications successfully processed imaging data, aligning with MRI and arthroscopic findings in cases like ACL and meniscus tears. Explainable AI visualizations clarified model decisions, highlighting key regions for complex injuries, such as concurrent ligament and soft tissue damage, enhancing clinical trust. This AI-driven model markedly improved the precision and efficiency of knee abnormality detection through X-ray analysis. By accurately identifying multiple coexisting conditions in a single pass, it offered a scalable tool to enhance diagnostic workflows and patient outcomes, especially in resource-constrained areas.

24 March 2026 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
AAAinikaer Abulaiti
Ainikaer Abulaiti
ZLZhen Liu
Zhen Liu
SQShi Qiu
Shi Qiu
MYMaihemuti Yakufu
Maihemuti Yakufu
PWPaerhati Wahafu
Paerhati Wahafu
YZYuxiang Zhang
Yuxiang Zhang
Analysis of 2004 articles outlines chondroitin sulfate's evolving trajectory in osteoarthritis treatment across three phases: pharmacological treatment, tissue engineering and biomaterials, and precise drug delivery.

14 November 2025 in Journal of Orthopaedics
Verified
Journal Article
Closed access
ZLZhen Liu
Zhen Liu
AAAinikaer Abulaiti
Ainikaer Abulaiti
YZYan Zhao
Yan Zhao
YZYuxiang Zhang
Yuxiang Zhang
GLGuohua Li
Guohua Li
MYMaihemuti Yakufu
Maihemuti Yakufu